EvalCriteria.pdf

Evaluation

The following technical evaluation criteria will be used in evaluating offers:

Offerors are advised that award will be made to that offeror whose proposal provides the combination of features that offers the best or greatest overall value to the Government. The Government is more concerned with obtaining performance capability superiority rather than lowest overall cost. However, the Government will not make an award at a significantly higher overall cost to the Government to achieve only slightly superior performance. Overall cost to the Government may become the ultimate determining factor for award of a contract as proposals become more equal based on the other factors.

TECHNICAL EVALUATION CRITERIA ARE AS FOLLOWS: The technical proposal will be evaluated on compliance with providing the specified items/services in Section B, and meeting the Statement of Work requirements specified in Section C and the Technical Evaluation Criteria. The evaluation criteria are used by the technical evaluation committee when reviewing the technical proposals. The criteria below are listed in the order of relative importance with weights assigned for evaluation purposes.

1. Understanding the Performance Requirements 35 points

We have developed a novel clinical decision tool to support the delivery of efficient, effective, evidence-based exercise advice to breast cancer survivors via individualized exercise discussions, prescriptions and/or referrals. The next step involves testing the clinical decision tool in a randomized controlled clinical trial involving breast cancer survivors and their clinicians to assess the impact of the tool on Exercise Prescriptions, Clinician Confidence, Exercise Referrals, Patient Satisfaction and Intention to Exercise, and Exercise Participation (up to 3-months post-intervention). NIMHD DIR does not have access to the target population to conduct this clinical trial. The overall purpose of this research is to establish a clinical trial protocol, obtain technical clearance, develop surveys, and establish data collection infrastructure necessary for a future clinical trial with breast cancer survivors and clinicians in real-world settings. There will be no data collection during this study period.

Approach: The offeror shall successfully perform the following specialized tasks,

• Preparation and submission of the offeror’s Technology Review Office approvals for clinical use of the web-based tool

• Preparation of the IRB submission packet in consultation with NIMHD DIR investigator, and submit for IRB approval at the offeror's institution

• Prepare and facilitate execution of the data sharing agreement between Contractor and NIMHD

• Develop study database for tracking study participants over the course of the study period

• Develop programs to identify eligible participants and curate related information for participant contact (e.g., email addresses, telephone numbers)

• Develop REDCap forms for all study surveys

• Promote study within the healthcare system

The offeror will also need to provide, o Provide monthly written status reports with activities completed, progress of ongoing activities, and any problems identified.

o Provide status reports on a weekly basis to assess progress, or more frequently as requested.

o Conduct bi-weekly phone meetings to discuss project updates and the next steps for web interface development.

o Provide documentation for the programs.

o Review and edit manuscripts for publication in peer-reviewed journals.

o Provide documentation of performance, information, data, and documents related to analyses.

o Maintain an itemized budget.

o Provide a semi-annual progress report.

o Continuous support throughout the performance period to troubleshoot any issues.

Regular Work Schedule: Five days a week; 9 am- 5 pm; excluding Federal holidays.

2. Experience and Knowledge of Key Personnel 35 points

The offeror needs to have at least 10 years of experience conducting breast cancer research within the healthcare systems. The offeror must also have previous experience obtaining IRB and technical clearance for intervention research. The offeror must have at least 50 clinicians and over 1000 breast cancer survivors eligible for the study.

Key Personnel should be currently employed by the Offeror.

3. Past Performance/Experience 15 points

The offeror must have successfully obtained technical and IRB clearance in a timely and efficient manner for other government and academic institutions.

Past performance and experience should also be evidenced by their publication record in high-impact journals and published clinical trials.

4) Ability to Deliver Timely Service 15 points

The offeror should deliver all the deliverables and reports within 12 months.